Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin

Annual Review of Immunology

Volumn 13, Issue , 1995, Pages 437-457

  Ulevitch, R J ^a   Tobias, P S ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

CD14; endotoxin; lipopolysaccharide binding protein; protein tyrosine phosphorylation; receptors

Indexed keywords

BINDING PROTEIN; CD14 ANTIGEN; ENDOTOXIN; LIPOPOLYSACCHARIDE; PROTEIN TYROSINE PHOSPHORYLASE; UNCLASSIFIED DRUG;

BACTERIAL INFECTION; BONE MARROW CELL; HOST RESISTANCE; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0028965644     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.iy.13.040195.002253     Document Type: Review

References (102)

1. Parrillo JE. 1993. Pathogenetic mechanisms of septic shock. New Engl. J. Med. 328:1471-77
2. Stone R. 1994. Search for sepsis drugs goes on despite past failures. Science 64:365-67
3. Natanson C, Hoffman WD, Suffredini, AF, Eichacker PQ, Danner RL. 1994. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann. Intern. Med. 120:771-83
4. Cohen J, Glauser MP. 1991. Septic shock: treatment. Lancet 338:736-39
5. Glauser MP, Zanetti G, Baumgartner J-D, Cohen J. 1991. Septic shock: pathogenesis. Lancet 338:732-36
6. Raetz CRH, Ulevitch RJ, Wright SD, Sibley CH, Ding A, Nathan CF. 1991. Gram-negative endotoxin: an extraordinary lipid with profound effects on eukaryotic signal transduction. FASEB J. 5:2652-60
7. Ulevitch RJ. 1993. Recognition of bacterial endotoxins by receptor-dependent mechanisms. Adv. Immunol. 53:267-89
8. Tobias P, Soldau K, Ulevitch R. 1986. Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum. J. Exp. Med. 164:777-93
9. Schumann RR, Leong SR, Flaggs GW, Gray PW, Wright SD, Mathison JC, Tobias PS, Ulevitch RJ. 1990. Structure and function of lipopolysaccharide binding protein. Science 249:1429-33
10. Tobias PS, Mathison JC, Ulevitch RJ. 1988. A family of lipopolysaccharide binding proteins involved in responses to gram-negative sepsis. J. Biol. Chem. 263:13479-81
11. Gray PW, Flaggs G, Leong SR, Gumina RJ, Weiss J, Ooi CE, Elsbach P. 1989. Cloning of the cDNA of a human neutrophil bactericidal protein. Structure and functional correlations. J. Biol. Chem. 264:9505-09
12. Day JR, Albers JJ, Lofton-Day CE, Gilbert TL, Ching AFT, Grant FJ, O'Hara, PJ, Marcovina SM, Adolphson JL. 1994. Complete cDNA encoding human phospholipid transfer protein from human endothelial cells. J. Biol. Chem. 269:9388-91
13. Mathison JC, Tobias PS, Wolfson E, Ulevitch RJ. 1992. Plasma lipopolysaccharide binding protein: a key component in macrophage recognition of gram-negative lipopolysaccharide (LPS). J. Immunol. 149:200-06
14. Ulevitch RJ, Tobias PS. 1994. Recognition of endotoxin by cells leading to transmembrane signalling. Curr. Opin. Immunol. 6:125-30
15. Wright SD, Tobias PS, Ulevitch RJ, Ramos RA. 1989. Lipopolysaccharide (LPS) binding protein opsonizes LPS-bearing particles for recognition by a novel receptor on macrophages. J. Exp. Med. 170:1231-41
16. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. 1990. CD14 serves as the cellular receptor for complexes of lipopolysaccharide with lipopolysaccharide binding protein. Science 249:1431-33
17. Bazil V, Baudys M, Hilgert I. Stefanova I, Low M, Brozek J, Horejsi V. 1989. Structural relationship between the soluble and membrane-bound forms of human monocyte surface glycoprotein CD14. Mol. Immunol. 26:657-62
18. Ziegler-Heitbrock HWL, Ulevitch RJ. 1993. CD14: cell surface receptor and differentiation marker. Immunol. Today 14:121-25
19. Pugin J, Schurer-Maly CC, Leturcq D, Moriarty A, Ulevitch RJ, Tobias PS. 1993. Lipopolysaccharide (LPS) activation of human endothelial and epithelial cells is mediated by LPS binding protein and soluble CD14. Proc. Natl. Acad. Sci. USA 90:2744-48
20. Frey EA, Miller DS, Jahr TG, Sundan A, Bazil V, Espevik T, Finlay BB, Wright SD. 1992. Soluble CD14 participates in the response of cells to lipopolysaccharide. J. Exp. Med. 176:1665-71
21. Rietschel ET, Kirikae T, Schade FU, Mamat U, Schmidt G, Loppnow H, Ulmer AJ, Zahringer U, Seydel U, di Padova F, Schreier M, Brade H. 1994. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J. 8:217-25
22. Jann K, Jann B. 1984. Structure and biosynthesis of O-antigens. In Handbook of Endotoxin, Vol. I. Chemistry of Endotoxin, ed. ET Rietschel, pp. 138-86. Amsterdam: Elsevier
23. Jansson P-E, Lindberg AA, Lindberg B, Wollin R. 1981. Structural studies on the hexose region of the core in lipopolysaccharide from Enterobactereaceae. Eur. J. Biochem. 115:571-77
24. Takada H, Kotani S. 1989. Structural requirements of lipid A for endotoxicity and other biological activities. CRC Crit. Rev. Microbiol. 16:477-23
25. Munford RS, Hall CL. 1986. Detoxification of bacterial lipopolysaccharides (endotoxins) by a human neutrophil enzyme. Science 234:203-05
26. Kitchens RL, Ulevitch RJ, Munford RS. 1992. Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway. J. Exp. Med. 176:485-94
27. Ramadori G, Meyer zum Buschenfelde K-H, Tobias PS, Mathison JC, Ulevitch RJ. 1990. Biosynthesis of lipopolysaccharide binding protein in rabbit hepatocytes. Pathobiology 58:89-94
28. Grube BJ, Cochrane CG, Ye RD, Ulevitch RJ, Tobias PS. 1994. Cytokine and dexamethasone regulation of lipopolysaccharide binding protein (LBP) expression in human hepatoma (HepG2) cells. J. Biol. Chem. 269:8477-82
29. Su GL, Freeswick PD, Geller DA, Wang Q, Shapiro RA, Wan Y-H, Billiar TR, Tweardy DJ, Simmons RL, Wang SC. 1994. Molecular cloning, characterization, and tissue distribution of rat lipopolysaccharide binding protein. J. Immunol. 153:743-52
30. Tobias PS, Soldau K, Ulevitch RJ. 1989. Identification of a lipid A binding site in the acute phase reactant lipopolysaccharide binding protein. J. Biol. Chem. 264:10867-71
31. Elsbach P, Weiss J. 1993. Bactericidal/permeability increasing protein and host defense against Gram-negative bacteria and endotoxin. Curr. Opin. Immunol. 5:103-07
32. Kirkland TN, Finley F, Leturcq D, Moriarty A, Lee J-D, Ulevitch RJ, Tobias PS. 1993. Analysis of lipopolysaccharide binding by CD14. J. Biol. Chem. 268:24818-23
33. Han J, Mathison J, Ulevitch R, Tobias P. 1994. LPS binding protein, truncated at Ile-197, binds LPS but does not transfer LPS to CD14. J. Biol. Chem. 269:8172-75
34. Tobias PS, Soldau K, Kline L, Lee JD, Kato K, Martin TP, Ulevitch RJ. 1993. Crosslinking of lipopolysaccharide to CD14 on THP-1 cells mediated by lipopolysaccharide binding protein. J. Immunol. 150:3011-21
35. Hailman E, Lichenstein HS, Wurfel MM, Miller DS, Johnson DA, Kelley M, Busse LA, Zukowski MM, Wright SD. 1994. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J. Exp. Med. 179:269-77
36. Weiss J, Elsbach P, Shu C, Castillo J, Grinna L, Horwitz A, Theofan G. 1992. Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant Gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria. J. Clin. Invest. 90:1122-30
37. Gazzano-Santoro H, Meszaros K, Birr C, Carroll SF, Theofan G, Horwitz AH, Lim E, Aberle S, Kasler H, Parent JB. 1994. Competition between rBPI23, a recombinant fragment of bactericidal/permeability-increasing protein, and lipopolysaccharide (LBP)-binding protein for binding to LPS and Gram-negative bacteria. Infect. Immun. 62:1185-91
38. Theofan G, Horwitz AH, Williams RE, Liu P-S, Chan I, Birr C, Carroll SF, Meszaros K, Parent JB, Kasler H, Aberle S, Trown PW, Gazzano-Santoro H. 1994. An amino-terminal fragment of human lipopolysaccaride-binding protein retains lipid A binding but not CD14-stimulatory activity. J. Immunol. 152:3623-29
39. Gray BH, Haseman JR. 1994. Bactericidal activity of synthetic peptides based on the structure of the 55-kilodalton bactericidal protein from human neutrophils. Infect. Immun. 62:2732-39
40. Hoess A, Watson S, Siber GR, Liddington R. 1993. Crystal structure of an endotoxin-neutralizing protein from the horseshoe crab, Limulus anti-LPS factor, at 1.5 Å resolution. EMBO J. 12:3351-56
41. Rustici A, Velucchi M, Faggioni R, Sironi M, Ghezzi P, Quataert S, Green B, Porro M. 1993. Molecular mapping and detoxification of the lipid A binding site by synthetic peptides. Science 259:361-65
42. Martin TR, Tobias PS, Mathison JC, Ulevitch RJ. 1994. Interactions between endotoxin and endotoxin binding protein. In Endotoxin and the Lungs, ed. K Brigham, 77:45-67. New York: Marcel Dekker
43. Martin TR, Mathison JC, Tobias PS, Maunder RJ, Ulevitch RJ. 1992. Lipopolysaccharide binding protein enhances the responsiveness of alveolar macrophages to bacterial lipopolysaccharide: implications for cytokine production in normal and injured lungs. J. Clin. Invest. 90:2209-19
44. Corradin SB, Mauel J, Ulevitch RJ, Tobias PS. 1992. Enhancement of murine macrophage binding of and response to bacterial lipopolysaccharide (LPS) by LPS-binding protein. J. Leukocyte Biol. 52:363-68
45. Wright SD, Ramos RA, Hermanowski-Vosatka A, Rockwell P, Detmers PA. 1991. Activation of the adhesive capacity of CR3 on neutrophils by endotoxin: dependence on lipopolysaccharide binding protein and CD14. J. Exp. Med. 173:1281-86
46. Surette ME, Palmantier R, Gosselin J, Borgeat P. 1993. Lipopolysaccharides prime whole human blood and isolated neutrophils for the increased synthesis of 5-lipoxygenase products by enhancing arachidonic acid availability: involvement of the CD14 antigen. J. Exp. Med. 178:1347-55
47. Gallay P, Heumann D, Le Roy D, Barras C, Glauser MP. 1993. Lipopolysaccharide-binding protein as a major plasma protein responsible for endotoxemic shock. Proc. Natl. Acad. Sci. USA 90:9935-38
48. Goyert SM, Ferrero E, Rertig WJ, Yenamandra AK, Obata F, LeBeau MM. 1988. The CD14 monocyte differentiation antigen maps to a region encoding growth factors and receptors. Science 239:497-500
49. Matsuura K, Setoguchi M, Nasu N, Higuchi Y, Yoshida S, Akizuki S, Yamamoto S. 1989. Nucleotide and amino acid sequences of the mouse CD14 gene Nucleic Acids Res. 17:2132
50. Pugin J, Ulevitch RJ, Tobias PS. 1993. A critical role for myeloid cells and CD14 in endotoxin-induced endothelial cell activation. J. Exp. Med. 178:2193-200
51. Duchow J, Marchant A, Crusiaux A, Husson C, Alonso-Vega C, De Groote D, Neve P, Goldman M. 1993. Impaired phagocyte responses to lipopolysaccharide in paroxysmal nocturnal hemoglobinuria. Infect. Immun. 61:4280-85
52. Haziot A, Chen S, Ferrera E, Low MG, Silber R, Goyert SM. 1988. The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidyl-inositol linkage. J. Immunol. 141:547-52
53. Bazil V, Strominger JL. 1991. Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. J. Immunol. 147:1567-74
54. Metz CM, Brunner G, Choi-Muira NH, Nguyen H, Gabrilove J, Caras IW, Altszuler N, Rifkin DB, Wilson EL, Davitz MA. 1994. Release of GPI-anchored membrane proteins by a cell-associated GPI-specific phospholipase D. EMBO J. 13:1741-51
55. Fearns C, Thinnes T, Roegner K, Kravchenko V, Ulevitch RJ, Loskutoff DJ. 1994. Murine CD14 gene expression in vivo: tissue distribution and regulation by lipopolysaccharide. FASEB J. 8:1019 (Abstr.)
56. Fearns C, Kravchenko V, Ulevitch RJ, Loskutoff D. 1994. Murine CD14 gene expression in vivo: tissue distribution and regulation by lipopolysaccharide. J. Exp. Med. In press
57. Ferrero E, Hsieh C-L, Francke U, Goyert SM. 1990. CD14 is a member of the family of leucine-rich proteins and is encoded by a gene syntenic with multiple receptor genes. J. Immunol. 145:331-36
58. Beekhuizen H, Blokland I, Corsel-van Tilburg AJ, Koning F, van Furth R. 1991. CD14 contributes to the adherence of human monocytes to cytokine-stimulated endothelial cells. J. Immunol. 147:3761-67
59. Lue K-H, Lauener RP, Winchester RJ, Geha RS, Vercelli D. 1991. Engagement of CD14 on human monocytes terminates T cell proliferation by delivering a negative signal to T cells. J. Immunol. 147:1134-38
60. Jabara HH, Vercelli D. 1994. Engagement of CD14 on monocytes inhibits the synthesis of human Igs, including IgE. J. Immunol. 153:972-78
61. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding proteins. Science 249:1431-33
62. Brown D. 1993. The tyrosine kinase connection: how GPI-anchored proteins activate T cells. Curr. Opin. Immunol. 5:349-54
63. Ferguson MAJ. 1994. What can GPI do for you? Parasitol. Today 10:48-52
64. Robinson PJ. 1991. Phosphatidylinositol membrane anchors and T-cell activation. Immunol. Today 12:35-41
65. Robinson PJ, Millrain M, Antoniou J, Simpson E, Mellor AL. 1989. A glycophospholipid anchor is required for Qa-2-mediated T cell activation. Nature 342:85-87
66. Shenoy-Scaria AM, Kwong J, Fujita T, Olszowy MW, Shaw AS, Lublin DM. 1992. Signal transduction through decay-accelerating factor. Interaction of glycosyl-phosphatidylinositol anchor and protein tyrosine kinases p56lck and p59fyn. J. Immunol. 149:3535-41
67. Su B, Waneck GL, Flavell RA, Bothwell ALM. 1991. The glycosyl phosphatidylinositol anchor is critical for Ly-6A/E-mediated T cell activation. J. Cell Biol. 112:377-84
68. Resta R, Hooker SW, Laurent AB, Shuck JK, Misumi Y, Ikehara Y, Koretzky GA, Thompson LF. 1994. Glycosyl phosphatidylinositol membrane anchor is not required for T cell activation through CD73. J. Immunol. 153:1046-53
69. Sato N, Miyajima A. 1994. Multimeric cytokine receptors: common versus specific functions. Curr. Opin. Cell Biol. 6:174-79
70. Weinstein SL, June CH, DeFranco AL. 1993. Lipopolysaccharide-induced protein tyrosine phosphorylation in human macrophages is mediated by CD14. J. Immunol. 151:3829-38
71. Lee JD, Kato K, Tobias PS, Kirkland TN, Ulevitch RJ. 1992. Transfection of CD14 into 70Z/3 cells dramatically enhances the sensitivity to complexes of lipopolysaccharide (LPS) and LPS binding protein. J. Exp. Med. 175:1697-05
72. Golenbock DT, Liu Y, Millham FH, Freeman MW, Zoeller RA. 1993. Surface expression of human CD14 in Chinese hamster ovary fibroblasts imparts macrophage-like responsiveness to bacterial endotoxin. J. Biol. Chem. 268:22,055-59
73. Lee J-D, Kravchenko V, Kirkland TN, Han J, Mackman N, Moriarty A, Leturcq D, Tobias PS, Ulevitch RJ. 1993. GPI-anchored or integral membrane forms of CD14 mediate identical cellular responses to endotoxin. Proc. Natl. Acad. Sci. USA 90:9930-34
74. Gallay P, Jongeneel CV, Barras C, Burnier M, Baumgartner J-D, Glauser MP, Heumann D. 1993. Short time ex-posure to lipopolysaccharide is sufficient to activate human monocytes. J. Immunol. 150:5086-93
75. Luchi M, Munford RS. 1993. Binding, internalization, and deacylation of bacterial lipopolysaccharide by human neutrophils. J. Immunol. 151:959-69
76. Anderson RGW, Kamen BA, Rothberg KG, Lacey SW. 1992. Potocytosis: sequestration and transport of small molecules by caveolae. Science 255:410-11
77. Matsuura K, Ishida T, Setoguchi M, Higuchi Y, Yamamoto S. 1993. Effect of antibodies against murine CD14 on LPS-induced TNFα production in vitro and in vivo, and endotoxin shock. J. Leukocyte Biol. Suppl. 484 (Abstr.)
78. Ferrero E, Jiao D, Tsuberi BZ, Tesio L, Rong GW, Haziot A, Goyert SM. 1993. Transgenic mice expressing human CD14 are hypersensitive to lipopolysaccharide. Proc. Natl. Acad. Sci. USA 90:2380-84
79. Maliszewski CR, Ball ED, Graziano RF, Fanger MW. 1985. Isolation and characterization of My23, a myeloid cell-derived antigen reactive with the monoclonal antibody AML-2-23. J. Immunol. 135:1929-36
80. Bazil V, Horejsi V, Baudys M, Kristofova H, Strominger J, Kostka W, Hilgert I. 1986. Biochemical characterization of a soluble form of the 53-kDa monocyte surface antigen. Eur. J. Immunol. 16:1583-89
81. Grunwald U, Kruger C, Westermann J, Lukowsky A, Ehlers M, Schutt C. 1994. An enzyme linked immunoassay for the quantification of solubilized CD14 in biological fluids. J. Immunol. Methods 155:225-32
82. Ulevitch RJ, Johnston AR, Weinstein DB. 1981. New function for high density lipoproteins (HDL). II. Isolation and characterization of a bacterial lipopolysaccharide-HDL complex formed in rabbit plasma. J. Clin. Invest. 67:827-37
83. Takeda J, Miyata T, Kawagoe K, Lida Y, Endo Y, Fujita T, Takahashi M, Kitani T, Kinoshita T. 1993. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell 73:703-11
84. Schutt C, Schilling T, Grunwald U, Schonfeld W, Kruger C. 1992. Endotoxin-neutralizing capacity of soluble CD14. Res. Immunol. 143:71-78
85. Haziot A, Rong G-W, Bazil V, Silver J, Goyert SM. 1994. Recombinant soluble CC14 inhibits LPS induced tumor necrosis factor-α produced by cells in whole blood. J. Immunol. 152:5868-76
86. Weinstein SL, Sanghera JS, Lemke K, DeFranco AL, Pelech SL. 1992. Bacterial lipopolysaccharide induces tyrosine phosphorylation and activation of mitogen-activated protein kinase in macrophages. J. Biol. Chem. 267:14955-62
87. Weinstein SL, Gold MR, DeFranco AL. 1991. Bacterial lipopolysaccharide stimulates protein tyrosine phosphorylation in macrophages. Proc. Natl. Acad. Sci. USA 88:4148-52
88. Novogrodsky A, Vanichkin A, Patya M, Gazit A, Osherov N, Levitzki A. 1994. Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors. Science 264:1319-22
89. Han J, Lee JD, Tobias PS, Ulevitch RJ. 1993. Endotoxin induces rapid protein tyrosine phosphorylation in 70Z/3 cells expressing CD14. J. Biol. Chem. 268:25009-14
90. Han J, Lee J-D, Bibbs L, Ulevitch RJ. 1994. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science. 265:808-11
91. Brewster JL, de Valoir T, Dyer ND, Winter E, Gustin MC. 1993. An osmosensing signal transduction pathway in yeast. Science 259:1760-63
92. Davis RJ. 1993. The mitogen-activated protein kinase signal transduction pathway. JBC J. Biol. Chem. 268:14,553-56
93. Franklin RA, Mazer B, Sawami H, Mills GB, Terada N, Lucas JJ, Gelfand EW. 1993. Platelet-activating factor triggers the phosphorylation and activation of MAP-2 kinase and S6 peptide kinase activity in human B cell lines. J. Immunol. 151:1802-10
94. Nishida E, Gotoh Y. 1993. The MAP kinase cascade is essential for diverse signal transduction pathways. Trends Biochem. Sci. 18:128-31
95. Lange-Carter CA, Pleiman CM, Gardner AM, Blumer KJ, Johnson GL. 1993. A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf. Science 260:315-19
96. Derijard B, Hibi M, Wu I-H, Barrett T, Su B, Deng T, Karin M, Davis RJ. 1994. JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the co-Jun activation domain. Cell 76:1025-37
97. Zhang F, Strand A, Robbins D, Cobb MH, Goldsmith EJ. 1994. Atomic structure of the MAP kinase ERK2 at 2.3 Å resolution. Nature 367:704-10
98. Maeda T, Wurgler-Murphy SM, Saito H. 1994. A two-component system that regulates an osmosensing MAP kinase cascade in yeast. Nature 369:242-45
99. Janeway CA Jr. 1992. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol. Today 13:11-16
100. Espevik T, Otterlei M, Skjak-Braek G, Ryan L, Wright SD, Sundan A. 1993. The involvement of CD14 in stimulation of cytokine production by uronic acid polymers. Eur. J. Immunol. 23:255-61
101. Zhang Y, Broser M, Rom WN. 1994. Activation of the interleukin 6 gene by Mycobacterium tuberculosis or lipopolysaccharide is mediated by nuclear factors NF-IL6 and NF-κB. Proc. Natl. Acad. Sci. USA 91:2225-29
102. Pugin J, Heumann D, Tomasz A, Kravchenko V, Akamatsu Y, Nishijimi M, Glauser M-P, Tobias PS, Ulevitch RJ. 1994. CD14 is a pattern recognition receptor. Immunity 1:509-16